Response to letter to the editor referencing manuscript the “Use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial”
暂无分享，去创建一个
[1] E. Shaw,et al. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Jett,et al. A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials , 2007, Cancer.
[3] A. Argyriou,et al. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation. , 2006, Journal of pain and symptom management.
[4] A. Argyriou,et al. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results , 2006, Supportive Care in Cancer.
[5] D. Sargent,et al. A comparison of simple single-item measures and the common toxicity criteria in detecting the onset of oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer , 2005 .
[6] A. Verma. Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial , 2010 .